APPENDIX 1.

Anchor-based and distribution-based MCID values for scales in osteoarthritis (OA).

ScaleMCID ImprovementMCID DeteriorationMCID Determined by Anchor MethodsMCID Determined by Distributional Methods
ESSRMSEMMDC90MDC95GRI
WOMAC pain*
  Knee and hip−8.3 to −7.5 (n = 2)6.4 to 11 (n = 2)
  Knee−29.9 to −7.5 (n = 3)27.1 to 29.9 (n = 1)0.98 to 1.86 (n = 2)0.91 to 1.55 (n = 2)8.08 to 8.6 (n = 2)22.39 (n = 1)1.2 to 1.74 (n = 1)
  Hip−29.26 to 35.8 (n = 2)−2.5 to 20 (n = 2)2.1 to 2.24 (n = 1)1.86 to 1.98 (n = 1)7.71 (n = 1)21.98 (n = 1)1.10 to 2.18 (n = 1)
WOMAC stiffness*
  Knee and hip−10.1 to −7.2 (n = 2)2.9 to 5.1 (n = 2)
  Knee−20.84 to −6.3 (n = 2)0.51 to 1.69 (n = 2)0.40 to 1.32 (n = 2)4.73 (n = 1)13.11 (n = 1)1.16 to 1.31 (n = 1)
  Hip−25.91 (n = 1)1.79 (n = 1)1.61 to 1.81 (n = 1)1.39 to 1.53 (n = 1)10.1 (n = 1)27.98 (n = 1)0.81 to 1.12 (n = 1)
WOMAC function*
  Knee and hip−8.0 to 6.7 (n = 2)10.3 to 13.3 (n = 2)
  Knee−33.5 to −5.3 (n = 6)32.8 to 33.9 (n = 1)0.66 to 1.32 (n = 3)0.64 to 1.13 (n = 3)4.6 to 10.5 (n = 2)29.12 (n = 1)0.56 to 0.62 (n = 1)
  Hip−26.54 to −9.42(n = 4)4.0 to 10.29 (n = 2)0.45 to 2.58 (n = 2)0.49 to 1.97 (n = 2)4.3 (n = 1)11.93 (n = 1)1.45 to 1.79 (n = 1)
WOMAC total*
  Knee and hip−8.2 to 6.7 (n = 2)9.6 to 12.9 (n = 2)
  Knee−11.5 to 11.5 (n = 2)0.96 to 1.19 (n = 1)0.91 to 1.13 (n = 1)4.8 to 7.2 (n = 1)11.2 to 16.7 (n = 1)13.4 to 20 (n = 1)0.85 to 1.00 (n = 1)
  Hip−14.7 (n = 1)
SF-36 PF
  Knee and hip3.3 (n = 1)−5.3 (n = 1)
  Knee0.75 to 17.5 (n = 3)0.1 to 1.10 (n = 3)0.33 to 0.83 (n = 2)7.03 to 7.74 (n = 2)14.52 (n = 1)19.5 (n = 1)0.38 to 0.66 (n = 1)
  Hip20.40 (n = 1)−8.75 (n = 1)1.54 to 1.60 (n = 1)1.10 (n = 1)6.85 (n = 1)18.99 (n = 1)1.50 to 1.54 (n = 1)
SF-36 RP
  Knee3.77 to 13.16 (n = 2)0.21 to 1.15 (n = 3)0.2 to 0.69 (n = 2)6.08 to 9.73 (n = 2)14.38 (n = 1)26.97 (n = 1)0.28 (n = 1)
  Hip10.78 (n = 1)−20.0 (n = 1)1.23 to 1.72 (n = 1)0.74 to 0.99 (n = 1)8.19 (n = 1)22.71 (n = 1)0.26 (n = 1)
SF-36 BP
  Knee and hip7.8 (n = 1)−7.2 (n = 1)
  Knee6.69 to 20.35 (n = 2)0.56 to 0.66 (n = 3)0.45 to 0.57 (n = 2)10.28 to 13.86 (n = 2)24.93 (n = 1)37.91 (n = 1)0.21 to 0.65 (n = 1)
  Hip14.67 (n = 1)−15.71 (n = 1)1.15 to 1.26 (n = 1)0.91 to 0.96 (n = 1)13.74 (n = 1)38.09 (n = 1)0.04 to 0.63 (n = 1)
SF-36 GH
  Knee−7.3 to 9.58 (n = 2)−0.07 to 0.32 (n = 2)−0.07 to 0.16 (n = 2)8.43 to 9.88 (n = 2)15.15 (n = 1)27.4 (n = 1)−0.31 to 0.04 (n = 1)
  Hip0.40 (n = 1)−1.71 (n = 1)0.09 to 0.25 (n = 1)0.09 to 0.27 (n = 1)10 (n = 1)27.73 (n = 1)0.04 to 0.63 (n = 1)
SF-36 VT
  Knee2.60 to 3.86 (n = 3)0.14 to 0.46 (n = 3)0.01 to 0.46 (n = 2)7.72 to 10.76 (n = 2)16.21 (n = 1)29.84 (n = 1)0.12 to 0.21 (n = 1)
  Hip10.14 (n = 1)−3.33 (n = 1)0.79 to 0.80 (n = 1)0.73 to 0.78 (n = 1)11.31 (n = 1)31.35 (n = 1)0.03 to 0.35 (n = 1)
SF-36 SF
  Knee6.15 to 11.66 (n = 2)0.04 to 0.57 (n = 3)0.29 to 0.58 (n = 2)8.7 to 14.87 (n = 2)24.33 (n = 1)41.23 (n = 1)−0.31 to 0.04 (n = 1)
  Hip8.63 (n = 1)−27.08 (n = 1)0.72 to 0.74 (n = 1)0.69 to 0.71 (n = 1)15.17 (n = 1)42.05 (n = 1)0.55 to 0.83 (n = 1)
SF-36 RE
  Knee2.42 to 7.65 (n = 2)0.15 to 0.48 (n = 3)0.16 to 0.49 (n = 2)5.86 to 10.29 (n = 2)16.3 (n = 1)28.52 (n = 1)0.04 to 0.17 (n = 1)
  Hip−6.45 (n = 1)−25.0 (n = 1)0.29 to 0.31 (n = 1)0.26 to 0.30 (n = 1)10.94 (n = 1)30.33 (n = 1)0.37 to 0.44 (n = 1)
SF-36 MH
  Knee−0.32 to 4.48 (n = 2)0.13 to 0.32 (n = 3)0.12 to 0.34 (n = 2)7.34 to 8.73 (n = 2)14.14 (n = 1)24.19 (n = 1)−0.02 to 0.16 (n = 1)
  Hip8.99 (n = 1)−12.0 (n = 1)0.54 to 0.56 (n = 1)0.54 to 0.60 (n = 1)8.42 (n = 1)23.33 (n = 1)−0.13 (n = 1)
SF-36 nPCS
  Knee4.6 to 4.8 (n = 1)0.44 to 0.98 (n = 2)0.41 to 1.00 (n = 2)
SF-36 nMCS
  Knee0.3 to 2.7 (n = 1)0.27 to 0.38 (n = 2)0.29 to 0.40 (n = 2)
  • * Scores standardized to 0–100 scale. n: number of articles; MCID: minimal clinically important difference; ES: effect size; SRM: standardized response mean; SEM: standard error of measurement; MDC90: minimum detectable change 90%; MDC95: minimum detectable change 95%; GRI: Guyatt’s responsiveness index; WOMAC: The Western Ontario and McMaster Universities Osteoarthritis Index; SF-36: Medical Outcomes Study Short Form-36; SF-36 PF: SF-36 physical functioning; SF-36 RP: SF-36 role physical; SF-36 BP: SF-36 bodily pain; SF-36 GH: SF-36 general health; SF-36 VT: SF-36 vitality; SF-36 SF: SF-36 social functioning; SF-36 RE: role emotional; SF-36 MH: SF-36 mental health; SF-36 nPCS: normalized physical component summary; SF-36 nMCS: normalized mental component summary.